PAVmed Inc. Common Stock

PAVMNASDAQ • USD
1.74 USD
↘ 0.02 (0.86%)🟢LIVE (AS OF 11:49 AM EST)
🟢Market: OPEN

PAVmed Inc. Common Stock (PAVM) is currently trading at $1.74. The technical outlook is "Sell" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, PAVM trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.69
High?$1.83
Low?$1.62
Prev. Close?$1.75
Volume?11.2K
Avg. Volume?20.3K
VWAP?$1.64
Rel. Volume?0.55x
Bid / Ask
Bid?$1.46 × 100
Ask?$2.02 × 100
Spread?$0.56
Midpoint?$1.74
Valuation & Ratios
Market Cap?14.0M
Shares Out?8.0M
Float?4.7M
Float %?59.1%
P/E Ratio?N/A
P/B Ratio?0.40
EPS?-$2.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
Employees
41
Market Cap
14.0M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2016-04-28
Address
360 MADISON AVENUE
NEW YORK, NY 10017
Phone: (212) 949-4319
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
77
Short Sent.?
90
Piotroski F-Score?4/9Mixed
Altman Z-Score?-10.71Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.27%Low
Short Interest?12.8K
Days to Cover?1.0
Free Float4.7M
Avg Daily Volume12.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.19Adequate
Quick Ratio?1.19Adequate
Cash Ratio?0.93Adequate
Debt/Equity?0.43Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.40CHEAP▾
P/S?
Peers
100
S&P
3
124.94HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.1CHEAP▾
EV/Sales?
Peers
100
S&P
3
225.97HIGH▾
Returns & Efficiency
ROE?
S&P
3
-58.9%WEAK▾
ROA?
S&P
3
-51.3%WEAK▾
Cash Flow & Enterprise
FCF?$-7782000
Enterprise Value?$25.3M
Fundamentals ratios updated end of day